Kuros Biosciences AG (CSBTF)

Kuros Biosciences AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,246	889	152	58	69	75
Market Cap Growth	430.93%	483.56%	162.24%	-16.11%	-7.51%	31.82%
Enterprise Value	1,225	875	136	37	42	61
Last Close Price	32.00	22.57	3.85	1.92	2.55	2.40
PS Ratio	9.59	10.66	3.82	2.99	4.57	16.40
PB Ratio	12.93	13.71	2.26	0.78	0.82	0.78
P/TBV Ratio	28.44	33.12	8.15	2.67	3.01	2.45
P/FCF Ratio	-	393.96	-	-	-	-
P/OCF Ratio	1208.48	256.57	-	-	-	-
EV/Sales Ratio	9.45	10.50	3.41	1.90	2.77	13.27
EV/EBITDA Ratio	150.52	385.86	-	-	-	-
EV/EBIT Ratio	253.31	7414.24	-	-	-	-
EV/FCF Ratio	-1445.60	387.93	-	-	-	-
Debt / Equity Ratio	0.02	0.03	0.04	0.03	0.03	0.03
Debt / EBITDA Ratio	0.28	0.66	-	-	-	-
Debt / FCF Ratio	-	0.88	-	-	-	-
Asset Turnover	1.10	0.97	0.44	0.21	0.15	0.04
Inventory Turnover	1.14	1.18	1.27	1.47	2.33	1.96
Quick Ratio	1.68	1.64	2.22	2.20	2.72	7.69
Current Ratio	2.25	2.14	2.77	2.49	2.91	8.76
Return on Equity (ROE)	-8.62%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%
Return on Assets (ROA)	2.57%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%
Return on Capital (ROIC)	3.43%	0.11%	-4.90%	-8.21%	-6.59%	-8.81%
Return on Capital Employed (ROCE)	4.60%	0.20%	-	-	-	-
Earnings Yield	-0.61%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%
FCF Yield	-0.07%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%
Buyback Yield / Dilution	-36.07%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.